Scott Allan Martin
Hausfeld LLP
- Address of record
- 165 Broadway, Suite 2301, New York, NY 00000, 212-357-1195
- smartin@hausfeld.com
- Phone
- (212) 357-1195
- Fax
- Fax 212-202-4322
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Visa Debit Card Antitrust Litigation
A proposed class action against Visa Inc., apparently concerning alleged antitrust violations involving Visa debit cards. The docket indicates the private action is being coordinated with a related U.S. Department of Justice case against Visa, and the parties are addressing scheduling. The specific claims are not detailed in this filing, and the allegations have not been proven.
- Filed
- October 1, 2024
- Represents
- NDA Aesthetics, LLC, Warren Imports, LLC, Ridgeline Roofing LLC
Uddin v. Elsevier Antitrust Class Action
A proposed class action against Elsevier, B.V., apparently concerning antitrust claims. The docket provides no further detail, so the specific alleged conduct is unclear. This case was filed in the Eastern District of New York under Nature of Suit 410 (Anti-Trust).
- Filed
- September 12, 2024
- Represents
- Lucina Uddin, Shelley Facente, Robert Mahon, Elvisha Dhamala
Granulated Sugar Antitrust Class Action
A proposed class action antitrust litigation involving granulated sugar. The docket caption and nature-of-suit code indicate alleged anticompetitive conduct, though no specific defendants or detailed allegations are available in the text. These are allegations only and have not been proven.
- Filed
- June 25, 2024
- Represents
- KPH Healthcare Services, Inc.
Interest Rate Swaps Antitrust Litigation Settlement
Defendants engaged in antitrust violations related to interest rate swaps. The defendants agreed to settle claims without admitting wrongdoing. This settlement includes multiple settlements, including one with Credit Suisse and a new settlement with other defendants.
- Claim deadline
- June 16, 2025
- Represents
- Kansas City, Missouri Employees' Retirement System
Blue Cross Blue Shield Antitrust Settlement
Blue Cross Blue Shield companies allegedly violated antitrust laws by entering into an agreement not to compete with each other and to limit competition among themselves in selling health insurance and administrative services. The defendants deny wrongdoing and claim their conduct results in lower healthcare costs and greater access to care. The parties settled to avoid the risk and cost of further litigation.
- Settlement fund
- $2.7B
- Claim deadline
- November 5, 2021
- Represents
- Plaintiffs' Counsel
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.